Processes for preparing montelukast sodium

Details Processes for preparing montelukast sodium Processes for preparing montelukast sodium

2005-04-21

2009-06-16

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S153000, C546S163000

Reexamination Certificate

active

07547787

ABSTRACT:
The present invention provides processes for preparing montelukast.

REFERENCES:
patent: 5428033 (1995-06-01), Belley et al.
patent: 5523477 (1996-06-01), King et al.
patent: 5565473 (1996-10-01), Belley et al.
patent: 5614632 (1997-03-01), Bhupathy et al.
patent: 5750539 (1998-05-01), Gareau et al.
patent: 5856322 (1999-01-01), Belley et al.
patent: 5952347 (1999-09-01), Arison et al.
patent: 6320052 (2001-11-01), Bhupathy et al.
patent: 6333198 (2001-12-01), Edmeades et al.
patent: 6716452 (2004-04-01), Piccariello et al.
patent: 7189853 (2007-03-01), Sundaram et al.
patent: 2005/0107426 (2005-05-01), Overeem et al.
patent: 2005/0107612 (2005-05-01), Reguri et al.
patent: 2005/0187243 (2005-08-01), Niddam-Hildesheim et al.
patent: 2005/0234241 (2005-10-01), Sundaram et al.
patent: 2006/0004204 (2006-01-01), Reguri et al.
patent: 0 480 717 (1992-04-01), None
patent: 0 500 360 (1992-08-01), None
patent: 1 904 448 (2008-04-01), None
patent: WO 95/18107 (1995-07-01), None
patent: WO 99/65888 (1999-12-01), None
patent: WO 03/066598 (2003-08-01), None
patent: WO 2004/091618 (2004-10-01), None
patent: WO 2004/108679 (2004-12-01), None
patent: WO 2005/040123 (2005-05-01), None
patent: WO 2005/073194 (2005-08-01), None
patent: WO 2005/074893 (2005-08-01), None
patent: WO 2006/008751 (2006-01-01), None
patent: WO 2006/043846 (2006-04-01), None
patent: WO 2006/058545 (2006-06-01), None
DuFresne,J Org Chem, VOI, pp. 8518-8525, 1996.
King, et al., “An Efficient Synthesis Of LTD4Antagonist L-699,392”,J. Org. Chem., 1993, pp. 3731-3735, vol. 58, No. 14.
Labelle, et al., “Discovery Of MK-0476, A Potent And Orally Active Leukotriene D4Receptor Antagonist Devoid Of Peroxisomal Enzyme Induction”,Bioorg. Med. Lett., 1995, pp. 283-288, vol. 5, No. 3.
Snyder, et al.,Introduction To Modern Liquid Chromatography, Second Ed., 1979, pp. 549, 552, 571-572.
Strobel, et al.,Chemical Instrumentation: A Systematic Approach, Third Ed., 1989, pp. 391-393, 894, 922, 924-925, 953.
Office Action from related U.S. Appl. No. 11/048,283, mailed Feb. 7, 2008.
Office Action from related U.S. Appl. No. 11/048,276, mailed Feb. 20, 2008.
Office Action from related U.S. Appl. No. 11/601,113, mailed Oct. 22, 2007.
Third Party Observation filed for European Application No. 067863696.2101.
Dufresne et al., “Synthesis of Montelukast (MK-0476) Metabolic Oxidation Prodcuts”, Journal of Organic Chemistry, (61) 8518-8525 (1996).
Guay et al., “A Series of Non-QuinolineCy5LT1Receptor Antagonist: SAR Study on Pyridyl Analogs of Singulair ©” Biorganic & Medicinal Chemistry Letters, 8(5) 453-458 (1998).

Affiliated with

Also associated with

Rating

Processes for preparing montelukast sodium does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Processes for preparing montelukast sodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for preparing montelukast sodium will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4057177